IP Library Granted Patent US 7,563,566
Granted Patent B2
US 7,563,566 · App. 11/648,911 · Granted Jul 21, 2009

Stabilization of H

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,563,566
App. No.
11/648,911
Granted
Jul 21, 2009
Kind
B2
Abstract

The invention relates to stannous halide stabilized and/or enhanced alkaline solutions to be used in combination with calorimetric, luminescent and fluorescent assays. The buffered solutions stabilize hydrogen peroxide at a pH greater than 7.0 and preferably greater than 9.0. By stabilizing and/or enhancing hydrogen peroxide in the buffer system, the compositions used in such assays may have a higher shelf-life and provide enhanced detection of the subject analyte.

Claims (16)

1. A method of conducting an assay for the presence or concentration of an analyte in an aqueous sample comprising: (A) admixing with said sample a heme containing protein which is coupled to a compound which binds specifically to said analyte; (B) removing unbound heme containing protein in said sample after said admixture; (C) admixing a composition comprising a peroxide, a peroxide stabilizing and/or enhancing amount of a stannous halide, a substrate and an alkaline buffer, wherein said composition has a pH of about 8.0 or greater; and (D) measuring the amount of detectable substrate obtained, wherein said detectable substrate obtained is indicative of the presence or concentration of said analyte.

2. The method of claim 1 , wherein said heme containing protein is peroxidase, said stannous halide is SnF 2 and said peroxide is hydrogen peroxide.

3. The method of claim 1 , wherein said compound which specifically binds to said analyte comprises an antibody or antibody fragment, a nucleic acid, a protein, or a hapten.

4. The method of claim 1 , wherein said detectable substrate comprises a chemiluminescent compound, a chemifluorescent compound and colorimetric compound.

5. The method of claim 4 , wherein said chemiluminescent compound comprises luminol, isoluminol, a polyphenol or a diacyl hydrazide.

6. The method of claim 4 , wherein said colorimetric compound comprises 3-amino-9-ethylcarbazole (AEC), 3,3′,4,4′-diaminobenzidene (DAB), 3,3′,5,5′-tetramethylbenzidine (TMB), 2,2′-azino-di[3-ethylbenthiazoline]sulfonate) (ABTS), 4-chloro-1-naphthol (4CN), 5-aminosalicyclic acid (5AS), o-phenylenediamine (OPD), Hanker-Yates, p-phenylenediamine (PPD), o-dianisidine, or analogs thereof.

7. The method of claim 1 , wherein said substrate is a chemiluminescent compound, said heme containing protein is peroxidase, and step (C) further comprises a peroxidase activity enhancer selected from the group consisting of N,N-dimethylindo-(aniline), 2,6-dichlorophenolindo-o-cresol, phenolindophenol, N-methylphenothiazine and mixtures thereof.

8. The method of claim 1 , wherein said heme containing protein is a peroxidase, a hemoglobin, a myoglobin, a catalase, a cytochrome oxidase or a territin.

9. The method of claim 1 , wherein the composition of step (c) has a pH of about 8.0 to about 10.0.

10. The method of claim 9 , wherein the pH is about 9.5.

11. A method for detecting the presence or concentration of a heme containing protein in a sample comprising: (A) adding to said sample a composition comprising (i) a peroxide, (ii) a substrate, (iii) a peroxide stabilizing and/or enhancing amount of a stannous halide, and (iv) an alkaline buffer, wherein said composition has a pH of about 8.0 or greater; and (B) measuring the amount of detectable substrate obtained by said reaction, wherein said detectable substrate is indicative of the presence or concentration of said heme containing protein.

12. The method of claim 11 , wherein said detectable substrate is detected by chemiluminescence, chemifluorescence or calorimetric analysis.

13. A method for detecting the presence or concentration of a peroxide in a sample comprising: (A) adding to said sample a composition comprising (i) a heme containing protein, (ii) a substrate, (iii)) a peroxide stabilizing and/or enhancing amount of a stannous halide, and (iv) an alkaline buffer, wherein said composition has a pH of about 8.0 or greater; and (B) measuring the amount of detectable substrate obtained by said reaction, wherein said detectable substrate is indicative of the presence or concentration of said peroxide.

14. The method of claim 13 , wherein said detectable substrate is detected by chemiluminescence, chemifluorescence or calorimetric analysis.

15. A method of performing in situ hybridization with a first nucleic acid which is attached to an indicator and wherein said first nucleic acid can hybridize to a second nucleic acid in a cell or a tissue sample obtained from a subject comprising the steps of: (A) obtaining a cell or tissue sample from said subject; (B) digesting said cell or said tissue sample with a proteinase; (C) performing in situ hybridization on said cell or said tissue sample obtained from step (B) with said first nucleic acid which specifically hybridizes to said second nucleic acid; (D) incubating said cell or said tissue sample from step (C) in a composition comprising a peroxide, a heme containing protein, a stannous halide, and an alkaline buffer; and (E) detecting said indicator bound to said first nucleic acid which is reacted by said heme containing protein.

16. The method of claim 15 , wherein said indicator comprises a luminescent indicator or a calorimetric indicator.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 8, 2025
From: SURMODICS IVD, INC.
To: SURMODICS HOLDINGS, LLC
Reel/Frame 073893/0928 →
RELEASE OF SECURITY INTEREST Recorded Nov 24, 2025
From: MIDCAP FUNDING IV TRUST
To: SURMODICS, INC.; SURMODICS SHARED SERVICES, LLC; SURMODICS HOLDINGS, LLC; SURMODICS COATINGS, LLC; SURMODICS MD, LLC; SURMODICS COATINGS MFG, LLC; SURMODICS IVD, INC.; SURMODICS MD OPERATIONS, LLC; NORMEDIX, INC.
Reel/Frame 073690/0186 →
SECURITY INTEREST Recorded Aug 23, 2024
From: SURMODICS, INC.; SURMODICS SHARED SERVICES, LLC; SURMODICS HOLDINGS, LLC; SURMODICS COATINGS, LLC; SURMODICS MD, LLC; SURMODICS COATINGS MFG, LLC; SURMODICS IVD, INC.; SURMODICS MD OPERATIONS, LLC; NORMEDIX, INC.
To: MIDCAP FUNDING IV TRUST
Reel/Frame 068762/0423 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 16, 2011
From: SURMODICS, INC.
To: SURMODICS IVD, INC.
Reel/Frame 026921/0105 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 21, 2007
From: BIOFX LABORATORIES, INC.
To: SURMODICS, INC.
Reel/Frame 019850/0873 →